*Pulmonary Disease, Chronic Obstructive/diagnosis/drug therapy/epidemiology

Suissa, S., Dell'Aniello, S., & Ernst, P. (2022). Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety. Int J Chron Obstruct Pulmon Dis, 17, 1975-1986. http://doi.org/10.2147/copd.s378486

View

Rebordosa, C., Plana, E., Rubino, A., Aguado, J., Martinez, D., Lei, A., et al. (2022). Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. Int J Chron Obstruct Pulmon Dis, 17, 1715-1733. http://doi.org/10.2147/copd.s363997

View

Sansbury, L. B., Lipson, D. A., Bains, C., Anley, G. A., Rothnie, K. J., & Ismaila, A. S. (2022). Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England. Int J Chron Obstruct Pulmon Dis, 17, 415-426. http://doi.org/10.2147/copd.s336158

View

Sansbury, L. B., Rothnie, K. J., Bains, C., Compton, C., Anley, G., & Ismaila, A. S. (2021). Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. Int J Chron Obstruct Pulmon Dis, 16, 2591-2604. http://doi.org/10.2147/copd.s318969

View